Whitehawk Therapeutics (WHWK) Treasury Shares (2015 - 2026)

Whitehawk Therapeutics (WHWK) has 8 years of Treasury Shares data on file, last reported at $2.4 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.4 million, up 1376.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 1376.99% YoY), and the FY2025 annual result was $2.5 million, up 856.25% from the prior year.
• Treasury Shares retreated to $2.4 million in Q1 2026 per WHWK's latest filing, from $2.5 million in the prior quarter.
• Over five years, Treasury Shares peaked at $2.5 million in Q4 2025 and troughed at $32558.0 in Q4 2023.
• A 4-year average of $1.1 million and a median of $337553.0 in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2025 and 2026: Treasury Shares sank 52.61% in 2025, then jumped 1376.99% in 2026.
• A 4-year view of Treasury Shares shows it stood at $32558.0 in 2023, then jumped by 687.79% to $256490.0 in 2024, then soared by 856.25% to $2.5 million in 2025, then declined by 2.61% to $2.4 million in 2026.
• Business Quant data shows WHWK's Treasury Shares at $2.4 million in Q1 2026, $2.5 million in Q4 2025, and $2.4 million in Q3 2025.